37.91
price up icon1.84%   0.685
after-market Handel nachbörslich: 37.91 0.005 +0.01%
loading

Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten

pulisher
Jul 25, 2025

What analysts say about Revolution Medicines Inc. stockSuperior stock selection - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Revolution Medicines, Iambic Therapeutics Partner to Use AI for Novel RAS-Addicted Cancer Drug Discovery - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Revolution Medicines Inc. Equity Warrant stock priceTriple returns potential - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Revolution Medicines Inc. Equity Warrant stockFastest-growing stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Revolution Medicines publishes research on RAS G12D inhibitor - Investing.com

Jul 25, 2025
pulisher
Jul 24, 2025

Revolution Medicines Inc. Equity Warrant Stock Analysis and ForecastHigh-octane financial growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Revolution Medicines Inc. stock priceBreakthrough stock performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is Revolution Medicines Inc. a good long term investmentMarket-leading capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the Discovery and Development of Zoldonrasib, a RAS(ON) G12D-Selective Inhibitor - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs - MSN

Jul 24, 2025
pulisher
Jul 23, 2025

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Revolution Medicines Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Castle Bio, Revolution Medicines get FDA breakthrough statuses - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

How will RVMD's EPS trend in Q1 2025? - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

Is Revolution Medicines Inc. Equity Warrant a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):